Updated Jul 16, 2026
Roberts David B has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $2.26M.

David B. Roberts is a corporate executive known for his roles as President and Director at Anteris Technologies Global Corp. and as a Director at LeMaitre Vascular Inc. He has been involved in the medical device industry, particularly focusing on products for vascular treatment.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | AVR | Anteris Technologies Global Corp. | M — Option exercise | 17.6K | — | |
| 2026-03-13 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale | 3.3K | $107.68 | $357K |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale | 8.5K | $106.80 | $904K |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 13 | $113.69 | $1K |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 134 | $113.69 | $15K |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 3 | $0.00 | |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | A — Grant or award | 146 | $0.00 | |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | A — Grant or award | 1.5K | $0.00 | |
| 2026-02-06 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 7 | $48.60 | $340 |
| 2026-02-06 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 2.7K | $37.29 | $100K |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 205 | $82.93 | $17K |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 11 | $0.00 | |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 230 | $82.93 | $19K |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 9 | $0.00 | |
| 2025-12-09 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 10 | $84.53 | $845 |
| 2025-12-09 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 99 | $84.53 | $8K |
| 2025-12-09 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 3 | $0.00 | |
| 2025-12-04 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 107 | $83.68 | $9K |
| 2025-12-04 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 15 | $0.00 | |
| 2025-08-11 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale | 6.7K | $92.35 | $620K |
David B. Roberts is a corporate executive known for his roles as President and Director at Anteris Technologies Global Corp. and as a Director at LeMaitre Vascular Inc. He has been involved in the medical device industry, particularly focusing on products for vascular treatment.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($2.26M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Roberts David B profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.